BACKGROUND & AIMS: Inactivation of the Apc gene is a critical early event in the development of sporadic colorectal cancer (CRC). Expression of serine-threonine kinase receptor associated protein (STRAP) is elevated in CRCs and is associated with poor outcomes. We investigated the role of STRAP in Apc mutation-induced intestinal tumor initiation and progression. METHODS: We generated Strap intestinal epithelial knockout mice (Strap(Delta IEC)) by crossing mice containing floxed alleles of Strap (Strap(fl/fl)) with Villin-Cre mice. Then we generated Apc(Min/+);Strap(fl/fl);Vill-Cre (Apc(Min/+) ;Strap(Delta IEC)) mice for RNA-sequencing analyses to determine the mechanism of function of STRAP. We used human colon cancer cell lines (DLD1, SW480, and HT29) and human and mouse colon tumor- derived organoids for STRAP knockdown and knockout and overexpression experiments. RESULTS: Strap deficiency extended the average survival of Apc(Min/+) mice by 80 days and decreased the formation of intestinal adenomas. Expression profiling revealed that the intestinal stem cell signature, the Wnt/beta-catenin signaling, and the MEK/ERK pathway are down-regulated in Strap-deficient adenomas and intestinal organoids. Correlation studies suggest that these STRAP-associated oncogenic signatures are conserved across murine and human colon cancer. STRAP associates with MEK1/2, promotes binding between MEK1/2 and ERK1/2, and subsequently induces the phosphorylation of ERK1/2. STRAP activated Wnt/beta-catenin signaling through MEK/ERK-induced phosphory- lation of LRP6. STRAP was identified as a target of mutated Apc and Wnt/beta-catenin signaling as chromatin immunopreci pitation and luciferase assays revealed pu- tative binding sites of the beta-catenin/TCF4 complex on the Strap promoter. CONCLUSIONS: STRAP is a target of, and is required in, Apc mutation/deletion-induced intestinal tumorigenesis through a novel feed-forward STRAP/MEK- ERK/Wnt-beta-catenin/STRAP regulatory axis.